Edition:
United Kingdom

BTG PLC (BTG.L)

BTG.L on London Stock Exchange

566.50GBp
4:21pm BST
Change (% chg)

3.50 (+0.62%)
Prev Close
563.00
Open
563.50
Day's High
577.50
Day's Low
562.00
Volume
545,922
Avg. Vol
939,189
52-wk High
784.00
52-wk Low
467.40

Chart for

About

BTG plc is medical device development and healthcare service provider. It provides Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care and licensing business. It operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and... (more)

Overall

Beta: 0.11
Market Cap(Mil.): £2,754.76
Shares Outstanding(Mil.): 386.36
Dividend: --
Yield (%): --

Financials

  BTG.L Industry Sector
P/E (TTM): 82.78 30.93 32.76
EPS (TTM): 0.09 -- --
ROI: 3.10 15.07 14.61
ROE: 3.68 16.59 16.33

Deals of the day-Mergers and acquisitions

Sept 7 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

07 Sep 2018

British healthcare firm BTG buys Irish vascular device maker

British healthcare company BTG Plc has acquired Irish medical device maker Novate Medical, adding to its portfolio a vascular device for managing blood clots.

07 Sep 2018

British healthcare firm BTG buys Irish vascular device maker

British healthcare company BTG Plc has acquired Irish medical device maker Novate Medical, adding to its portfolio a vascular device for managing blood clots.

07 Sep 2018

CORRECTED-British healthcare firm BTG buys Irish vascular device maker

Sept 7 British healthcare company BTG Plc has acquired Irish medical device maker Novate Medical, adding to its portfolio a vascular device for managing blood clots.

07 Sep 2018

Brazil court acquits former BTG Pactual CEO Esteves

SAO PAULO, July 12 A Brazilian federal judge on Thursday acquitted Banco BTG Pactual SA's founder and main partner André Esteves in a corruption probe, according to court documents.

12 Jul 2018

BRIEF-BTG full-year operating profit up 18 pct

* ADJUSTED BASIC EPS 1 32.9P UP 42 PERCENT Source text for Eikon: Further company coverage: (Reporting By London Bureau)

15 May 2018

Earnings vs. Estimates